Correlation Between Zealand Pharma and Bavarian Nordic

Can any of the company-specific risk be diversified away by investing in both Zealand Pharma and Bavarian Nordic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zealand Pharma and Bavarian Nordic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zealand Pharma AS and Bavarian Nordic, you can compare the effects of market volatilities on Zealand Pharma and Bavarian Nordic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zealand Pharma with a short position of Bavarian Nordic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zealand Pharma and Bavarian Nordic.

Diversification Opportunities for Zealand Pharma and Bavarian Nordic

0.79

Correlation Coefficient

Zealand Pharma  Bavarian Nordic

Poor diversification

The 3 months correlation between Zealand and Bavarian is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Zealand Pharma AS and Bavarian Nordic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bavarian Nordic and Zealand Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zealand Pharma AS are associated (or correlated) with Bavarian Nordic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bavarian Nordic has no effect on the direction of Zealand Pharma i.e., Zealand Pharma and Bavarian Nordic go up and down completely randomly.

Pair Corralation between Zealand Pharma and Bavarian Nordic

Assuming the 90 days trading horizon Zealand Pharma AS is expected to generate 0.88 times more return on investment than Bavarian Nordic. However, Zealand Pharma AS is 1.13 times less risky than Bavarian Nordic. It trades about -0.08 of its potential returns per unit of risk. Bavarian Nordic is currently generating about -0.13 per unit of risk. If you would invest  87,000  in Zealand Pharma AS on September 2, 2024 and sell it today you would lose (14,000) from holding Zealand Pharma AS or give up 16.09% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Zealand Pharma AS  vs.  Bavarian Nordic

Zealand Pharma AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bavarian Nordic

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bavarian Nordic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Zealand Pharma and Bavarian Nordic

The main advantage of trading using opposite Zealand Pharma and Bavarian Nordic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zealand Pharma position performs unexpectedly, Bavarian Nordic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bavarian Nordic will offset losses from the drop in Bavarian Nordic's long position.

The idea behind Zealand Pharma AS and Bavarian Nordic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.